Target intelligence / Profile preview

Choroideremia-like Rab escort protein 2 (CHML)

Target
CHML
Molecular classification
Other (Rab escort protein family; protein involved in post-translational modification)
01

Overview

Choroideremia-like Rab escort protein 2 (CHML, also known as REP-2) is a cytosolic protein that supports the geranylgeranylation (a lipid modification) of most Rab GTPase proteins, which are essential for vesicular trafficking in eukaryotic cells[1][2][3][4]. REP-2 binds newly synthesized Rab proteins and presents them to Rab geranylgeranyltransferase for prenylation, a process required for proper Rab protein localization and function in intracellular membrane transport[2][3]. While REP-1 (encoded by the CHM gene) is critical in the retina and its deficiency causes choroideremia, REP-2 (CHML) can substitute for REP-1 in other tissues, thereby preventing systemic cellular dysfunction[1][2][3]. REP-2’s specific contribution outside the retina and in noncanonical contexts like asthma remains incompletely characterized[1]. There are no known drugs directly targeting CHML, nor is it currently considered a therapeutic target or biomarker[4].

Other names
Rab escort protein 2REP-2choroideremia-like proteinRab proteins geranylgeranyltransferase component A 2CHMLREP2choroideraemia-like proteinchoroideremia-like (Rab escort protein 2)
02

Biological functions

Protein prenylationIntracellular vesicular traffickingRab GTPase processing
03

Disease associations

Other (Potential link to choroideremia via functional compensation for REP-1; candidate for asthma susceptibility)

Beyond the preview

Go deeper on Choroideremia-like Rab escort protein 2 (CHML).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Choroideremia-like Rab escort protein 2 (CHML).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call